Skye Bioscience

0 followers

‌

Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Punit Dhillon

CEO

Punit Dhillon

Collapse

Kaitlyn Arsenault

Chief Financial Officer

Tu Diep

Chief Development Officer

Chris Twitty

Chief Scientific Officer

Karam Takhar

VP, Corporate Development & Investor Relations

Teams

Advisory & Clinical Team

6 members

Directors

5 members

Leadership Team

3 members

Similar companies

Exo

3 followers

Bristol-Myers Squibb

163 followers

NYU Langone Health

12 followers

Parexel

4 followers

Clario

4 followers

Curia Global

4 followers

Charlie Health

4 followers

PPD

15 followers

Incyte

14 followers

Amgen

179 followers

Mirum Pharmaceuticals

3 followers

Discover companies